Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | CASP1 | P29466 | 1/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.65 |
| ▸ | ATP6V1B2 | P21281 | 1/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.65 |
| ▸ | EDNRA | P25101 | 1/20 | 0.65 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.62 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pipemidic Acid SCHEMBL29351712 | 1.00 | LMNA (0.82) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL27316221 | 1.00 | LMNA (0.82) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL675597 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL28034962 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL28034340 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL9935838 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL9073067 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL11872870 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL28757085 | 0.99 | LMNA (0.80) | LMNACASP1KDM4ECYP2C9ATP6V1B2 | |
| Pipemidic Acid SCHEMBL11870978 | 0.98 | LMNA (0.78) | LMNACASP1KDM4ECYP2C9ATP6V1B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6249 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12350281-B2 | Long-acting injectable formulations and use thereof | DECHRA VETERINARY PRODUCTS, LLC (US) | 2025-07-08 | — | — | US | claimed |
| EP-4571306-A1 | STABILIZING OXYGEN IN A COMPOSITION | Instrumentation Laboratory Company (US) | 2025-06-18 | — | — | EP | claimed |
| CN-120142412-A | Stabilizing oxygen in a composition | 仪器实验室公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250189479-A1 | STABILIZING OXYGEN IN A COMPOSITION | INSTRUMENTATION LABORATORY COMPANY | 2025-06-12 | — | — | US | claimed |
| EP-4554939-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2025-05-21 | — | — | EP | claimed |
| EP-4554627-A1 | INHALABLE FORMULATION FOR USE IN THE TREATMENT OF BACTERIAL LUNG INFECTIONS | Solmic Biotech GmbH (DE) | 2025-05-21 | — | — | EP | claimed |
| US-20250144088-A1 | INHALABLE FORMULATION FOR USE IN THE TREATMENT OF BACTERIAL LUNG INFECTIONS | Solmic Biotech GmbH (DE) | 2025-05-08 | — | — | US | claimed |
| WO-2025080590-A1 | CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-17 | — | — | WO | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20250115942-A1 | SCREENING METHOD FOR ANTI-PSEUDOMONAL AGENTS AND COMPOSITIONS AND METHODS FOR TREATING PSEUDOMONAS INFECTIONS | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES | 2025-04-10 | — | — | US | claimed |
| EP-0405858-A2 | Control of aberrant expression vector accumulation during fermentation procedures | ELI LILLY AND COMPANY (US) | 1991-01-02 | — | — | EP | claimed |
| CN-1045701-A | The preparation method of medicine applied on urethra | CENTRAL HOSPITAL OF SHENYANG R (CN) | 1990-10-03 | — | — | CN | claimed |
| US-4853225-A | Process for implanting a medicament depot | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-08-01 | — | — | US | claimed |
| EP-0130119-B1 | (ACYLOXYALKOXY) CARBONYL DERIVATIVES AS BIOREVERSIBLE PRODRUG MOIETIES FOR PRIMARY AND SECONDARY AMINE FUNCTIONS IN DRUGS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES | MERCK & CO. INC. (US) | 1988-11-09 | — | — | EP | claimed |
| US-4760057-A | (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs | MERCK & CO., INC. (US) | 1988-07-26 | — | — | US | claimed |
| CN-85100992-A | Material for industrial reactor for producing dehydrogenated ester by illumination method | — | 1987-01-31 | — | — | CN | claimed |
| US-4563485-A | SURGICAL IMPLANTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1986-01-07 | — | — | US | claimed |
| EP-0130119-A2 | (Acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives | MERCK & CO. INC. (US) | 1985-01-02 | — | — | EP | claimed |
| US-4034094-A | 8-Alkyl-5-oxo-5,8-dihydro-pyrido(2,3-d)pyrimidine-6-carboxylic acids for treating urinary tract infections | LABORATOIRE ROGER BELLOW (FR) | 1977-07-05 | — | — | US | claimed |
| US-3950338-A | BACTERICIDES | LABORATOIRE ROGER BELLON (FR) | 1976-04-13 | — | — | US | claimed |